Condition: Colo-rectal Cancer · Sponsor: Guardant Health, Inc.
The Shield post-approval study (PAS) is a prospective, longitudinal study supplemented with Real World Evidence (RWE) to evaluate the longitudinal performance of Shield in an average risk population at a second round of testing for individuals between the ages of 45 and 81 at average risk of CRC using colonoscopy as the reference method.
This description comes directly from the study's public registry record.
Hannah Oakley · 415-307-2774 · solar@guardanthealth.com
Always discuss trial participation with your own doctor first.
| Southeast Valley Gastroenterology Consultants | Chandler, Arizona, United States | Recruiting |
| Southeast Valley Gastroenterology Consultants | Gilbert, Arizona, United States | Recruiting |
| Alliance Research Institute, LLC | Canoga Park, California, United States | Recruiting |
| Paragon Rx Clinical, Inc. | Garden Grove, California, United States | Withdrawn |
| Amicis Research Center | Granada Hills, California, United States | Recruiting |
| Desert Oasis Healthcare Medical Group | Palm Springs, California, United States | Recruiting |
| Digestive Disease Associates | Branford, Connecticut, United States | Recruiting |
| Digestive Disease Associates | Branford, Connecticut, United States | Recruiting |
| Gastroenterology Consultants of Boca Raton, LLC | Boca Raton, Florida, United States | Recruiting |
| Physicians Group of South Florida | North Miami, Florida, United States | Recruiting |
| Digestive Disease Consultants | Bourbonnais, Illinois, United States | Recruiting |
| Digestive Disease Consultants | Bourbonnais, Illinois, United States | Recruiting |
+ 44 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06880055